FDA review date set for birth control device:
This article was originally published in Clinica
Executive Summary
Conceptus' minimally invasive device for permanent birth control is scheduled for review by US FDA advisors during the July 22-23 meeting of the agency's Obstetrics and Gynecology Devices Panel. This Essure device is delivered by a hysteroscopic procedure, without the need for an abdominal incision and, in most women, the placement procedure does not require general anaesthesia, says the San Carlos, California firm.